Can Multidrug-Resistant Candidaauris Be Reliably Identified in Clinical Microbiology Laboratories?

Candida auris, an emerging multidrug-resistant yeast associated with a high mortality rate, has been increasingly reported outside the United States to cause outbreaks in hospital settings ([1][1]). Although this organism is rare in the United States, its prevalence may be underestimated because of